Home Podcasts We're not getting any younger... yet.
We're not getting any younger... yet.

We're not getting any younger... yet.

The Buck Institute 35 Episodes Jun 24, 2026

Why do some of us age gracefully and others don’t? How do our bodies and minds experience aging at the cellular and molecular level? Why do we even age to begin with? And maybe most importantly, can we do anything about it? Join hosts Eric Verdin, CEO of the Buck Institute in California, and Brianna Stubbs, Director of Translational Science at the Buck, as they speak with some of the brightest scientific stars on the planet to search for – and actually find answers to – these questions and many more.

Episodes

Q&A with Eric and Brianna
Q&A with Eric and Brianna Jun 24, 2026 2440 In the final episode of season 3 we answer your biggest aging questions, from whether there is a single root cause of aging to why different organs fail in different ways. We also dig into what it would take to run human trials that prove real healthspan gains while staying honest about biomarkers, animal data, and online misinformation.Eric Verdin, MD and Brianna Stubbs, PhDDr. Eric Verdin is Pre
Brad Younggren: Filtering Out Aging
Brad Younggren: Filtering Out Aging Jun 10, 2026 2522 What if removing and replacing part of your blood could turn back some of the measurable signs of aging? Brianna Stubbs talks with Dr. Brad Younggren — emergency physician, former Army doctor, and CEO of Circulate Health — about therapeutic plasma exchange (TPE). They cover how the procedure works, what the blinded Circulate trial found (including an average 2.6-year reduction in biological age ov
Hanadie Yousef: Cracking the Secretome Code
Hanadie Yousef: Cracking the Secretome Code Apr 1, 2026 2102 In this episode, Buck scientist Brianna Stubbs joins Hanadie Yousef, Co-Founder of Juvena Therapeutics, to discuss the cutting-edge of longevity science. Dr. Yousef shares how Juvena is leveraging AI and the secretome—the proteins secreted by stem cells—to develop therapies that target muscle wasting and promote tissue regeneration. From the potential and risks of GLP-1 drugs to the role of AKT si
Cynthia Kenyon: Switching on Resilience
Cynthia Kenyon: Switching on Resilience Mar 18, 2026 2272 Eric Verdin sits down with Dr. Cynthia Kenyon, a true pioneer in the field of geroscience and the Vice President of Aging Research at Calico. Dr. Kenyon recounts the revolutionary discovery that aging is not merely a process of "wearing out," but is a genetically regulated biological program. In 1993, Cynthia’s pioneering discovery that a single-gene mutation could double the lifespan of
Ana Maria Cuervo: Cellular Recycling
Ana Maria Cuervo: Cellular Recycling Mar 4, 2026 2803 What if the secret to a longer, healthier life isn’t found in a new supplement or a complex medical procedure, but in your cells' own innate ability to "take out the trash"? In this episode, host Eric Verdin is joined by Dr. Ana Maria Cuervo, a pioneer in the biology of aging and professor at the Albert Einstein College of Medicine. The conversation explores the critical roles of pr
Jamie Justice: The New Metrics of Functional Aging
Jamie Justice: The New Metrics of Functional Aging Feb 18, 2026 2126 XPRIZE Healthspan Executive Director Jamie Justice joins Brianna Stubbs to discuss the $101 million race to restore 10 years of muscle, cognitive, and immune function within a single year. Moving past binary "alive or dead" metrics—famously called the "toes test" in animal research—the conversation focuses on reclaiming functional independence through clinical trial innovation.
Tony Wyss-Coray: Rejuvenating the Brain
Tony Wyss-Coray: Rejuvenating the Brain Feb 4, 2026 2741 In this episode, Eric Verdin, CEO of the Buck Institute, and Stanford University’s Dr. Tony Wyss-Coray discuss the groundbreaking science of brain rejuvenation through heterochronic parabiosis, a process where young blood factors are shown to restore cognitive function and potentially extend lifespan. Moving from the lab to the clinic, they explore the next frontier: Proteomic Clocks. By measuring
George Church: Rewriting The Rules of Aging
George Church: Rewriting The Rules of Aging Jan 21, 2026 2378 What if aging is less a fate and more an engineering challenge? We sit down with George Church to unpack a future where gene therapy, cellular reprogramming, and AI-driven delivery systems converge to extend healthspan—and possibly lifespan—without sacrificing identity or safety. From bowhead whales and cancer risk to ethics, trial rigor, and how to deliver rejuvenation to the brain, this is a dee
Season 3 Trailer
Season 3 Trailer Jan 14, 2026 44 We're back! Meet our new hosts Eric Verdin, CEO of the Buck Institute, and Brianna Stubbs, Director of Translational Science at the Buck. We're excited to bring you new insights into the fast-moving science of longevity with guests such as George Church, Jamie Justice, Peter Attia, and many more.Support the show
Nathan Price: Scientific Wellness and AI at the Forefront
Nathan Price: Scientific Wellness and AI at the Forefront Jul 24, 2024 1950 What do we really want from our healthcare system, and how can AI help us get it sooner? In our final episode of season two, Gordon talks with visionary systems biology expert Nathan Price about the emergence of scientific wellness, what we can learn from our digital twins, and how using AI to predict health outcomes can help us transform our understanding of aging and disease—potentially adding y
Luigi Ferrucci: Resilience as Medicine
Luigi Ferrucci: Resilience as Medicine Jul 10, 2024 2774 Few people have as much experience with patient care and long-term research as the celebrated geriatrician and epidemiologist Luigi Ferrucci. Listen in as he speaks with Gordon about his journey from acute care to population studies, the effective design of clinical trials, and moving towards predictive medicine so we can use our natural resilience to maintain health as we age.Dr. Luigi Ferrucci i
Andrea Maier: From Potential to Practice
Andrea Maier: From Potential to Practice Jun 12, 2024 2183 The movement to integrate longevity treatments into clinical care is making strides. How can we ensure they are evidence-based, accessible, and personalized? World-renowned geroscientist Andrea Maier has been leading the way with innovative clinical trials and cutting edge research. In this episode, she talks with Gordon about the current state of the field, why we need a variety of clocks and int

Recommended